All terms in GO
| Label | Id | Description |
|---|---|---|
| negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO_1902042 | [Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.] |
| negative regulation of extrinsic apoptotic signaling pathway | GO_2001237 | [Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway.] |
| positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO_1902043 | [Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.] |
| positive regulation of extrinsic apoptotic signaling pathway | GO_2001238 | [Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway.] |
| regulation of Fas signaling pathway | GO_1902044 | [Any process that modulates the frequency, rate or extent of Fas signaling pathway.] |
| Fas signaling pathway | GO_0036337 | [A series of molecular signals initiated by the binding of a ligand to the receptor Fas on the surface of the cell, and ending with regulation of a downstream cellular process, e.g. transcription. Fas is a death domain-containing member of the tumor necrosis factor receptor (TNFR) superfamily.] |
| negative regulation of Fas signaling pathway | GO_1902045 | [Any process that stops, prevents or reduces the frequency, rate or extent of Fas signaling pathway.] |
| positive regulation of Fas signaling pathway | GO_1902046 | [Any process that activates or increases the frequency, rate or extent of Fas signaling pathway.] |
| polyamine transmembrane transport | GO_1902047 | [The process in which a polyamine macromolecule is transported across a membrane.] |
| polyamine transport | GO_0015846 | [The directed movement of polyamines, organic compounds containing two or more amino groups, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.] |
| neosartoricin metabolic process | GO_1902048 | [The chemical reactions and pathways involving neosartoricin.] |
| acetate ester metabolic process | GO_1900619 | [The chemical reactions and pathways involving an acetate ester, any carboxylic ester where the carboxylic acid component is acetic acid.] |
| neosartoricin catabolic process | GO_1902049 | [The chemical reactions and pathways resulting in the breakdown of neosartoricin.] |
| polyketide catabolic process | GO_0030640 | [The chemical reactions and pathways resulting in the breakdown of polyketides, any of a diverse group of natural products synthesized via linear poly-beta-ketones, which are themselves formed by repetitive head-to-tail addition of acetyl (or substituted acetyl) units indirectly derived from acetate (or a substituted acetate) by a mechanism similar to that for fatty acid biosynthesis but without the intermediate reductive steps.] |
| neosartoricin biosynthetic process | GO_1902050 | [The chemical reactions and pathways resulting in the formation of neosartoricin.] |
| polyketide biosynthetic process | GO_0030639 | [The chemical reactions and pathways resulting in the formation of polyketides, any of a diverse group of natural products synthesized via linear poly-beta-ketones, which are themselves formed by repetitive head-to-tail addition of acetyl (or substituted acetyl) units indirectly derived from acetate (or a substituted acetate) by a mechanism similar to that for fatty acid biosynthesis but without the intermediate reductive steps.] |
| acetate ester biosynthetic process | GO_1900620 | [The chemical reactions and pathways resulting in the formation of an acetate esteran acetate ester, any carboxylic ester where the carboxylic acid component is acetic acid.] |
| (25S)-Delta(4)-dafachronate binding | GO_1902051 | [Interacting selectively and non-covalently with (25S)-Delta(4)-dafachronate.] |
| (25S)-Delta(7)-dafachronate binding | GO_1902052 | [Interacting selectively and non-covalently with (25S)-Delta(7)-dafachronate.] |
| regulation of neosartoricin biosynthetic process | GO_1902053 | [Any process that modulates the frequency, rate or extent of neosartoricin biosynthetic process.] |